Postdoctoral Research Scientist
Ahmed's background is in molecular cell biology and transgenic animal models for disease, specifically retinal disease. After completing his BSc (Honours) in Genetics at the University of Glasgow, Ahmed joined Sir William Dunn School of Pathology at the University of Oxford in 2009 and completed his MSc by research in mouse embryonic development in 2013 where he gained his experience in transgenic animal models. He later joined the Welcome Trust Centre for Human Genetics (currently Welcome Centre for Human Genetics) at the University of Oxford working on DNA double-stranded break repair mechanisms before starting his PhD in developing a transgenic murine model for Nystagmus, a significant eye disease with uncontrolled eye movements at the University of Southampton in 2014.
Ahmed joined Professor MacLaren's group in 2019 working on characterising preclinical models for gene therapy using a variety of viral and non-viral delivery approaches of gene editing technologies such as CRISPR.
Insights on the Regeneration Potential of Müller Glia in the Mammalian Retina
Salman A. et al, (2021), Cells, 10, 1957 - 1957
CRISPR genome engineering for retinal diseases
Kantor A. et al, (2021), Progress in Molecular Biology and Translational Science
Characterization of the Frmd7 Knock-Out Mice Generated by the EUCOMM/COMP Repository as a Model for Idiopathic Infantile Nystagmus (IIN)
Salman A. et al, (2020), Genes, 11, 1157 - 1157
In Vitro Characterisation of Spontaneously Immortalised Non-Human Primate (NHP) Muller Glia Cell Lines as a Potential Source for Cell Replacement Therapies for Retinal Degenerative Eye Disease
Salman A., (2020), MOLECULAR THERAPY, 28, 366 - 366
REV7 counteracts DNA double-strand break resection and affects PARP inhibition
Xu G. et al, (2015), Nature, 521, 541 - 544